Keep vials shielded from light, ideally in their original outer packaging
The worst-case scenario isnt taking medication and regaining weight
However, the dietary changes and altered digestive transit associated with these medications may indirectly affect stool appearance
What factors of GLP-1 coverage drive up premiums Using data from MarketScan and research by Blue Health Intelligence (BHI), the EBRI report models how GLP-1 coverage could affect employer-sponsored insurance premiums, exploring several scenarios based on: Drug pricing Net costs range from $617 to $766 per 30-day supply Patient adherence Perfect adherence leads to higher premiums due to sustained drug use Eligibility criteria Including overweight individuals with at least one weight-related condition significantly increases cost burden Cost-sharing Cost-sharing structures such as $90 copays help but dont eliminate increases Usage is growing More than 57 million privately insured adults qualify for GLP-1 drugs, like Ozempic and Wegovy

Why Your Patients May Need Semaglutide Physicians prescribe Semaglutide for patients who: Struggle with obesity or difficulty losing weight Have type 2 diabetes or prediabetes and need better glycemic control Experience insulin resistance or metabolic syndrome Require a non-stimulant weight loss solution Want to reduce their cardiovascular risk factors How Semaglutide Works Semaglutide mimics the GLP-1 hormone, which plays a key role in glucose metabolism and appetite regulation
KFF health tracking poll May 2024: The publics use and views of GLP-1 drugs